Meta-analysis of efficacy and safety of dual antiplatelet therapy versus aspirin monotherapy after coronary artery bypass grafting

Eur J Prev Cardiol. 2019 Jan;26(2):215-218. doi: 10.1177/2047487318788613. Epub 2018 Jul 18.
No abstract available

Publication types

  • Letter
  • Meta-Analysis
  • Review

MeSH terms

  • Aged
  • Aspirin / administration & dosage*
  • Aspirin / adverse effects
  • Coronary Artery Bypass* / adverse effects
  • Coronary Artery Bypass* / mortality
  • Coronary Thrombosis / mortality
  • Coronary Thrombosis / prevention & control
  • Dual Anti-Platelet Therapy* / adverse effects
  • Dual Anti-Platelet Therapy* / mortality
  • Female
  • Graft Occlusion, Vascular / mortality
  • Graft Occlusion, Vascular / prevention & control
  • Hemorrhage / chemically induced
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / mortality
  • Myocardial Infarction / physiopathology
  • Myocardial Infarction / surgery*
  • Patient Safety
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Aggregation Inhibitors / adverse effects
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Risk Assessment
  • Risk Factors
  • Stroke / mortality
  • Stroke / prevention & control
  • Time Factors
  • Treatment Outcome
  • Vascular Patency / drug effects

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin